FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Basilic Fly Studio IPO and Saroja Pharma Industries IPO.
Basilic Fly Studio IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Saroja Pharma Industries IPO is a SME Fixed Price Issue proposed to list at NSE SME.
Basilic Fly Studio IPO | Saroja Pharma Industries IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Fixed Price Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | GYR Capital Advisors Private Limited | Swastika Investmart Ltd |
Registrar | Purva Sharegistry India Pvt Ltd | Kfin Technologies Limited |
Market Maker | Share India Securities Limited | Swastika Investmart Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Basilic Fly Studio IPO is up to ₹66.35 Cr whereas the issue size of the Saroja Pharma Industries IPO is up to ₹9.11 Cr. The final issue price of Basilic Fly Studio IPO is ₹97.00 per share and of Saroja Pharma Industries IPO is ₹84.00 per share.
Basilic Fly Studio IPO | Saroja Pharma Industries IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹92.00 per share | |
Issue Price (Upper) | ₹97.00 per share | |
Issue Price (Final) | ₹97.00 per share | ₹84.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1200 shares | 1600 shares |
Fresh Issue Size | 62,40,000 shares | 10,84,800 shares |
Fresh Issue Size (Amount) | up to ₹60.53 Cr | up to ₹9.11 Cr |
OFS Issue Size | 6,00,000 shares | |
OFS Issue Size (Amount) | up to ₹5.82 Cr | |
Issue Size Total | 68,40,000 shares | 10,84,800 shares |
Issue Size Total (Amount) | up to ₹66.35 Cr | up to ₹9.11 Cr |
Basilic Fly Studio IPO opens on Sep 01, 2023, while Saroja Pharma Industries IPO opens on Aug 31, 2023. The closing date of Basilic Fly Studio IPO and Saroja Pharma Industries IPO is Sep 05, 2023, and Sep 05, 2023, respectively.
Basilic Fly Studio IPO | Saroja Pharma Industries IPO | |
---|---|---|
Anchor Bid Date | Aug 31, 2023 | |
Issue Open | Sep 01, 2023 | Aug 31, 2023 |
Issue Close | Sep 05, 2023 | Sep 05, 2023 |
Basis Of Allotment (Tentative) | Sep 11, 2023 | Sep 08, 2023 |
Initiation of Refunds (Tentative) | Sep 12, 2023 | Sep 11, 2023 |
Credit of Share (Tentative) | Sep 13, 2023 | Sep 12, 2023 |
Listing date (Tentative) | Sep 14, 2023 | Sep 13, 2023 |
Anchor Lockin End date 1 | Oct 11, 2023 | Oct 08, 2023 |
Anchor Lockin End date 2 | Dec 10, 2023 | Dec 07, 2023 |
Basilic Fly Studio IPO P/E ratio is 5.94, as compared to Saroja Pharma Industries IPO P/E ratio of 23.27.
Basilic Fly Studio IPO | Saroja Pharma Industries IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Lakhs |
Amount in ₹ Lakhs |
|||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 85.42% | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 5.94 | 23.27 | |||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹225.43 Cr. | ₹33.77 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 155.63%% | 0.15%% | |||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 104.73%% | 0.25%% | |||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.14 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹16.32 | ₹3.61 | |||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 87.59%% | 20.85%% |
In the Basilic Fly Studio IPO retail investors (RII) are offered 20,35,200 shares while in Saroja Pharma Industries IPO retail investors are offered 20,35,200 shares. Qualified institutional buyers (QIB) are offered 11,62,800 shares in Basilic Fly Studio IPO and 0 shares in Saroja Pharma Industries IPO.
Basilic Fly Studio IPO | Saroja Pharma Industries IPO | |
---|---|---|
Anchor Investor Reserveration | 17,43,600 shares | |
Market Maker Reserveration | 10,26,000 shares | 54,400 shares |
QIB | 11,62,800 shares | 0 shares |
NII | 8,72,400 shares | 5,15,200 shares |
RII | 20,35,200 shares | 5,15,200 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 40,70,400 shares | 10,30,400 shares |
Basilic Fly Studio IPO subscribed 358.60x in total, whereas Saroja Pharma Industries IPO subscribed 8.88x.
Basilic Fly Studio IPO | Saroja Pharma Industries IPO | |
---|---|---|
QIB (times) | 116.34x | |
NII (times) | 549.44x | 2.90x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 415.22x | 14.83x |
Employee (times) | ||
Other (times) | ||
Total (times) | 358.60x | 8.88x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|